1[1]Muller C,Goubin F,Ferrandis E,et al.Evidence for transcriptional control of human mdrl gene expression by verapamil in multidrug-resistant leukemic cells.Mol Pharmcol,1995,47 (1):51-56
2[2]Morita T,Shinohara N,Horma,et al.Establishment and characterization of a multidrug resistant human bladder carcinoma cell line RT112/D21.Urol Res,1995,22(3):143-149
3[3]Abe T,Koike K,Ohga T,et al.Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpression MRP or mrdl.Br J Cancer,1995,72(2):418-423
4[4]Raderer M,Scheithauer W.Clinical traials of agents that reverse multidrug resistance.A literature review.Cancer,1993,72(12):3553-3563
5[5]Slater LM,Swee P,Stupecky M,et al.Cyclosporin A correct daunorubicin resistance in Ehrlich ascites carinoma.Br J Cancer,1986,54(2):235-238
6[6]Yahanda AM,Alder KM,Fisher GA,et al.Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.J Clin Oncol,1992,10(10):1624-1634
7[7]Schwabe K,Steinheider G,Lawen A,et al.Reversal of multidrug resistance by noval cyclosporin A analogues and the cyclopeptolide SDZ 214-103 biosynthesized in vitro.J Cancer Res Clin Oncol,1995,121(7):407-412
8[8]Nabioullin R,Yanagawa H,Haku T,et al.Influence of systemic chemotherapy on anti-p-glycoprotein antibody-dependent cell-mediated cytotoxicity in patients with small cell lung cancer.Jpn J Clin Oncol,1995,25(4):124-130
9[9]Tsuruo T.Mechanism of multidrug resistant tumors and chemotherapeutic approaches against the resistant tumors.Yakugaku Zasshi,1997,117 (8):455-467
10[10]Naito M,Tsuge H,Kuroko C,et al.Enhancement of cellular accumulation of cyclosporin A by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.J Natl Cancer Inst,1993,85(4):311-316
